Clinical Trials in France / NCT06890078
Recruiting
Observational
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
NCT06890078 · tracked via the Priya Life Science France tracker
Condition(s) studied
PneumocystisImmunocompromised Patients
Investigational drug(s) / intervention(s)
Biological sampling
Biological sampling: Mouthwash, nasopharyngeal swab, blood sampling
Study summary
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Eligibility
Inclusion Criteria:
* adult patients with suspected pneumocystis
* with an indication for bronchial fibroscopy for BAL or induced sputum
* no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition
Exclusion Criteria:
* Pneumocystis treated for more than 72 hours
* pregnancy/breast-feeding
* adult patients deprived of liberty, protected
Primary outcome measure(s)
- Pearson correlation coefficient — At inclusion
Pearson correlation coefficient between the fungal load obtained by PCR on nasopharyngeal swabs nasopharyngeal swab and buccal lavage and that obtained by reference samples (induced sputum or BAL) in patients with confirmed PcP.
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Lariboisière AP-HP Maladies infectieuses | Paris | France | Recruiting |
| Hôpital Saint Louis AP-HP Maladies infectieuses | Paris | France | Recruiting |
| Hôpital Saint Louis AP-HP Réanimation | Paris | France | Recruiting |
| Hôpital Saint-Louis AP-HP Pneumologie | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06890078 on ClinicalTrials.gov ↗ ← All trials in France